Tocilizumab shows promise in refractory Graves orbitopathy
- Posted on: Dec 4 2018
- Leave a response
Investigators examined the efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant Graves orbitopathy (GO).
Source: AAO
Posted in: Uncategorized
